🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the efficacy, safety, and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-21
Trial ID
NCT04732117
Treatments Being Tested
This multicenter, randomized, double-blind, active-controlled study aims to...
Status
Active Not Recruiting
Location
Dermatology Hospital of Shandong First Medical University (Shandong Provincial Hospitial of Dermatology)
Start Date
2025-05-27
Trial ID
NCT06945107
Treatments Being Tested
This study assessed efficacy of secukinumab, compared to ustekinumab, in pa...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-26
Trial ID
NCT02074982
Treatments Being Tested
This study will establish whether prolonged chronic dosing with secukinumab...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-03-28
Trial ID
NCT05622708
Treatments Being Tested
The purpose of this study is to demonstrate the impact of secukinumab on th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-11-30
Trial ID
NCT03259074
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
This study will assess the safety and efficacy of secukinumab on the preser...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-02
Trial ID
NCT02044848
Treatments Being Tested
This was a pivotal, randomized, double-blind, placebo-controlled trial eval...
Status
Terminated
Location
University Of Alabama
Start Date
2020-07-07
Trial ID
NCT04181762
Treatments Being Tested
The purpose of this study was to provide up to 52 weeks of efficacy, safety...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-01-29
Trial ID
NCT04209205
Treatments Being Tested
This study will assess the efficacy and safety of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-09-29
Trial ID
NCT02267135
Treatments Being Tested